Previous studies have shown that blocking VEGFA‐VEGFR2 signalling with soluble VEGFR1 can accelerate the progression of glomerulosclerosis, loss of PTCs, and interstitial fibrosis [50]. The gene discussed is FLT1; the disease is glomerulosclerosis.